[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$inzy

$INZY faces scrutiny after trial data causes a significant drop, with analysts comparing its risk profile to other biotech names. Recent social posts highlight concerns following the trial results.

About $inzy

$inzy is a biotechnology company.

Engagements: X (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XXXXX
X Week: XXX -XX%
X Month: XXXXX +147%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -X%
1-Year High: XXXXXXX on 2025-05-16
1-Year Low: X on 2025-10-11

Engagements by network (24h): X: X

Mentions: X (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XX +106%
X Months: XXXXX -XX%
X Year: XXXXX +1,071%
1-Year High: XXX on 2025-05-17
1-Year Low: X on 2025-09-25

Mentions by network (24h): X: X

Creators: X (24h)

Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $inzy in the last XX hours which is no change from in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XX +150%
X Months: XXX -XX%
X Year: XXXXX +1,774%
1-Year High: XXX on 2025-05-17
1-Year Low: X on 2025-09-25

Top $inzy Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Biotech names like $TVTX and $NAMS interesting but risky after seeing $INZY and others crater on trial data. $ISRG's device business has different risk profile entirely"
X Link @_samputnam 2025-11-26T14:36Z 1050 followers, 1158 engagements